Font Size:
a
A
A
Keyword [programmed cell death-1]
Result: 21 - 40 | Page: 2 of 3
21.
Levels Of PD-1, PD-L1 And CTLA-4 In The Peripheral Blood Of Patients With Esophageal Squamous Cell Carcinoma And Its Clinical Implications
22.
Antagonists Of The PD-1/PD-L1 Axis In Head And Neck Cancer Treatment:Current Status And Future Directions
23.
Preparation Of Fusion Protein Of PD-L1 Single-chain Antibody And Verification Of Its Antitumor Activity
24.
The Expressions And Clinical Significance Of PD-L1 In Diffuse Large B Cell Lymphomas
25.
Expression Of PD-1 And PD-L1 In Ovarian Tumors A Nd Its Clinical Significance
26.
Expression Of PD-1/PD-L1 In Esophageal Squamous Cell Carcinoma And Its Prognostic Value
27.
Notch Signaling Pathway Was Involved In Regulating Programmed Cell Death 1 Expression During Sepsis-induced Immunosuppression
28.
Prognostic Significance Of CD3+CD8+Tumor-Infiltrating Lymphocyte(TILs) And Programmed Cell Death 1 Ligand 1(PD-L1)Expression In Papillary Thyroid Carcinoma
29.
Clinicopathological And Prognostic Significance Of Programmed Cell Death 1 Ligand 1 Expression In Patients With Esophageal Squamous Cell Carcinoma:A Meta-analysis
30.
Study On The Preventive Effect And Mechanism Of Jincao Disinfection Granule On DEN-Induced Hepatocellular Carcinoma In Rats
31.
Expression And Significance Of PD-1/PD-L1 On T Cell And Dendritic Cell In Sepsis
32.
Correlations Between The Expression Of PD-1/PD-L1 In Pulmonary Sarcomatoid Carcinoma And Its Clinical Characteristics
33.
Significance Of TIM-3 Expression In Esophageal Squamous Cell Carcinoma
34.
Preliminary Study On The Inhibitory Effect Of PD-0332991 On The Proliferation Of Gastric Cancer Cells
35.
The Expression Of PD-1/PD-L1 In HNSCC Tissues And The Expression And Dynamic Changes Of SPD-L1 In Peripheral Blood
36.
IDO1 Expression Characteristics And Prognostic Value In Upper Urinary Tract Urothelial Carcinoma
37.
Y Chromosome Traces The Micro-chimerism Of Exogenous Tolerant DCs In CIA Rats
38.
On The The Role Of γδT Cell Subsets In Unexplained Recurrent Abortion
39.
A High-throughput Screening Model To Screen Synergistic Drugs With Humanized PD1 Antibody In Vitro,and The Efficacy Of PD1 Antibody Combined With Romidepsin In The Treatment Of Murine NK-T Cell Lymphoma In Vivo
40.
Efficacy And Safety Of Programmed Cell Death 1 Inhibitor Monotherapy Versus Chemotherapy As Second-Line Treatment For Advanced Esophageal Cancer:A Meta-Analysis
<<First
<Prev
Next>
Last>>
Jump to